Summation
- “It is a privilege to have the opportunity to join such a high-performing team focused on improving the health of patients around the world.
- Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced the appointment of Julia James as the company’s Chief Legal and Administrative Officer.
- Her extensive legal and compliance expertise will help us continue to advance Clario’s impact in clinical trials, further enhancing our efforts on quality and speed to empower our partners to transform lives.
Julia James
Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced the appointment of Julia James as the company’s Chief Legal and Administrative Officer. This appointment bolsters Clario’s strategic focus on improving the customer experience and differentiating its offerings.
Chris Fikry, M.D., Chief Executive Officer at Clario
“We are excited to welcome Julia James to Clario. Her extensive legal and compliance expertise will help us continue to advance Clario’s impact in clinical trials, further enhancing our efforts on quality and speed to empower our partners to transform lives.”
Past Experience
Julia James served as Executive Vice President and General Counsel of PPD, the leading contract research organization, until its acquisition by Thermo Fisher Scientific in 2021. She then continued as General Counsel, Clinical Research, following the transaction. Julia spent more than 15 years in various legal leadership roles at PPD and, prior to that, worked for the international law firm Clifford Chance in both London and Dubai. She is passionate about empowering women in business to succeed individually and collectively.
“Clario plays a pivotal role in the clinical trial ecosystem through the generation of the highest quality evidence and developing transformative technologies,” she said. “It is a privilege to have the opportunity to join such a high-performing team focused on improving the health of patients around the world.”
